These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36731780)

  • 1. Infections after organ transplantation and immune response.
    Elalouf A
    Transpl Immunol; 2023 Apr; 77():101798. PubMed ID: 36731780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".
    Roberts MB; Fishman JA
    Clin Infect Dis; 2021 Oct; 73(7):e1302-e1317. PubMed ID: 32803228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Profiling of Kidney Transplant Recipients With Immunosuppressive Treatment Reveals the Dynamic Immune Characteristics.
    Liu Y; Liu X; Zhou S; Xu R; Hu J; Liao G; Liao J; Guo Z; Li Y; Yang S; Li S; Chen H; Guo Y; Li M; Fan L; Li L; Zhao M; Liu D
    Front Immunol; 2021; 12():639942. PubMed ID: 33959124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor repertoires within liver allografts are different to those in the peripheral blood.
    Mederacke YS; Nienen M; Jarek M; Geffers R; Hupa-Breier K; Babel N; Reinke P; Mederacke I; Vondran FWR; Jonigk D; Wedemeyer H; Jaeckel E
    J Hepatol; 2021 May; 74(5):1167-1175. PubMed ID: 33347951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
    Duncan MD; Wilkes DS
    Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts.
    Sundstrom JB; Ansari AA
    Transpl Immunol; 1995 Dec; 3(4):273-89. PubMed ID: 8665146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD8+ T cells during allograft rejection.
    Bueno V; Pestana JO
    Braz J Med Biol Res; 2002 Nov; 35(11):1247-58. PubMed ID: 12426623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J
    Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of immune tolerance in liver transplantation].
    Pons JA; Revilla-Nuin B; Ramírez P; Baroja-Mazo A; Parrilla P
    Gastroenterol Hepatol; 2011 Mar; 34(3):155-69. PubMed ID: 21376423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis in the post-transplantation inflammatory response.
    Bai YZ; Kopecky BJ; Lavine KJ; Kreisel D
    Cell Immunol; 2023; 393-394():104774. PubMed ID: 37839157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P;
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and regulation of alloreactive T cell immunity in solid organ transplantation.
    Duneton C; Winterberg PD; Ford ML
    Nat Rev Nephrol; 2022 Oct; 18(10):663-676. PubMed ID: 35902775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection, Rejection, and the Connection.
    Higdon LE; Tan JC; Maltzman JS
    Transplantation; 2023 Mar; 107(3):584-595. PubMed ID: 36017937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation.
    Martin-Gandul C; Mueller NJ; Pascual M; Manuel O
    Am J Transplant; 2015 Dec; 15(12):3024-40. PubMed ID: 26474168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of immunosuppression: implications for composite tissue allograft transplantation.
    Hricik DE
    Transplant Proc; 1998 Sep; 30(6):2721-3. PubMed ID: 9745554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of human skin allografts in patients with immunosuppression.
    Wendt JR; Ulich T; Rao PN
    Plast Reconstr Surg; 2004 Apr; 113(5):1347-54. PubMed ID: 15060346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.